Disease/Infection News

RSS

Echinacea as a potential force against coronavirus infections

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.

21 Jan 2022

Alphacoronaviruses found to be common in bats in the upper Midwestern United States

In a new study, researchers used a pan-coronavirus PCR to screen bats submitted for rabies testing owing to human exposure in order to find potentially novel bat CoVs that may represent a concern to people.

21 Jan 2022

Researchers design neural network to predict severity of COVID-19 variants

In a new study, researchers predict the risk of infection with severe coronavirus disease 2019 from the sequence of the spike protein.

21 Jan 2022

Vaccines alone are ineffective against the widely circulating Omicron variant

Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19.

21 Jan 2022

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

In a new study, researchers assessed the efficacy of the FDA-approved therapeutic mAbs, as well as to small-molecule antiviral agents against the SARS-CoV-2 Omicron variant in Syrian hamsters.

21 Jan 2022

Study supports that Omicron variant has shifted to better usage of Cathepsin B/L entry pathway

A new study analyzed new data on the Omicron variant and indicated the altered cell entry pathways compared to other variants.

21 Jan 2022

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Several deadly pandemics have emerged in human history that have either disappeared or turned into epidemics. Researchers explored the likelihood that SARS-CoV-2 would also eventually become an endemic disease.

21 Jan 2022

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

The focus of this study was to investigate the evolution of PTSD symptoms in cancer patients over the first year of the COVID19 pandemic.

21 Jan 2022

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

The goal of the current study was to collect data on the prevalence of SARS-CoV-2 in bivalve mollusks harvested in the Campania region using dd RT-PCR for the detection of low levels of virus in mollusk tissues.

21 Jan 2022

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

A new study showed that the SARS-CoV-2 Omicron spike binds to its receptor with enhanced affinity and yet evades vaccine-elicited neutralizing antibodies and that a booster mRNA vaccine broadened the neutralization of Omicron.

21 Jan 2022

Relationship between SARS-CoV-2 infection rates and government-implemented stringency measures in Africa

Researchers ask: how can they evaluate the effects of policy measures on socioeconomic conditions to their effectiveness in stopping the spread of the virus?

21 Jan 2022

Call for pharmaceutical companies to release COVID-19 vaccine data

Scientists are beginning to grow worried about the seeming reluctance of these companies to release the raw data from the clinical trials.

21 Jan 2022

Patient, beware: Some states still pushing ineffective covid antibody treatments

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer work against the highly contagious version of the virus that causes covid-19.

21 Jan 2022

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

In the present study published in PLOS ONE, researchers designed and undertook a unique study to investigate these interactions further.

21 Jan 2022

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice.

21 Jan 2022

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

The Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA) are bringing together the inflammatory bowel disease (IBD) care community for the fifth annual Crohn's & Colitis Congress®, taking place virtually Jan. 20 through 22, 2022.

21 Jan 2022

New production method developed to freeze-dry COVID-19 vaccines

UMass Lowell scientists are developing a production method to freeze-dry COVID-19 vaccines activated by messenger-RNA so they can be transported and stored at room temperature.

21 Jan 2022

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

COVID-19 vaccination does not impair fertility, suggests BU study

New findings by Boston University School of Public Health investigators indicate that COVID-19 vaccination does not impair fertility - but males who become infected by the coronavirus may experience short-term reduced fertility.

21 Jan 2022

Disease/Infection News

Echinacea as a potential force against coronavirus infections

Alphacoronaviruses found to be common in bats in the upper Midwestern United States

Researchers design neural network to predict severity of COVID-19 variants

Vaccines alone are ineffective against the widely circulating Omicron variant

Study shows monoclonal antibody and antiviral therapy are useful in preventing the severity of SARS-CoV-2 Omicron infection

Study supports that Omicron variant has shifted to better usage of Cathepsin B/L entry pathway

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

New COVID-19 vaccine promises vaccine equity because it has no patents

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Relationship between SARS-CoV-2 infection rates and government-implemented stringency measures in Africa

Call for pharmaceutical companies to release COVID-19 vaccine data

Patient, beware: Some states still pushing ineffective covid antibody treatments

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

New production method developed to freeze-dry COVID-19 vaccines

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

COVID-19 vaccination does not impair fertility, suggests BU study

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News